QUESILLE VILLALOBOS, ANA MARIA
Preferred name
QUESILLE VILLALOBOS, ANA MARIA
Main Affiliation
Email
aquesille@gmail.com
ORCID
0000-0002-6992-3407
Scopus Author ID
55626173100
4 results
Now showing 1 - 4 of 4
- Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - Geographic divergence of methicillin-resistant Staphylococcus aureus ST5-SCCmecI in the aftermath of a major earthquake and tsunami: impact of a plasmid harboring heavy metal resistance genes(United States National Library of Medicine, 2025); ; ; ;ROBERTO ANDRES RIQUELME NEIRA - Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - Dynamics of the MRSA Population in a Chilean Hospital: a Phylogenomic Analysis (2000-2016)(2023) ;MARTINEZ SOLIS, JOSE RODRIGO WALDEMAR ;SPENCER SANDINO, MARÍA DE LOS ÁNGELES; ;DIAZ ORTIZ, SANDRA5 - Some of the metrics are blocked by yourconsent settings
Item type:Product, 11 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Multispecies emergence of dual blaKPC/NDM carbapenemase-producing Enterobacterales recovered from invasive infections in Chile(American Society for Microbiology, 2025-01-31); ;Camila Solar ;Jose R. W. Martínez; Valeria QuirozCarbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) represent a significant global threat. The emergence of dual CP-CRE is particularly alarming, as they can potentially compromise the efficacy of newer antibiotics, further decreasing therapeutic alternatives. Herein, we report the emergence of multiple species of CP-CRE recovered from invasive infections in Chile that simultaneously harbor and provide an in-depth genomic characterization of these worrisome pathogens. We collected carbapenem-resistant Enterobacterales (CRE) isolates from invasive infections over a 4-year period, across 11 healthcare centers in Chile. Bacterial species and the presence of carbapenemase genes were confirmed using MALDI-TOF and PCR assays, respectively. Antimicrobial susceptibility testing was conducted through disk diffusion and broth microdilution methods. Dual CP-CRE isolates were subjected to short- and long-read whole genome sequencing to perform a detailed genomic characterization of the isolates and of the mobile genetic elements harboring the enzymes. From a total of 1,335 CRE isolates, we observed an increase in the prevalence of CP-CRE, from 11% in 2019 to 38% in 2022. A total of 11 dual CP-CRE isolates were recovered, all of them harboringScopus© Citations 10 15